Summary

Eligibility
for people ages 6 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
completion around
Principal Investigator
by Michael Geschwind, MD
Headshot of Michael Geschwind
Michael Geschwind

Description

Summary

Official Title

Clinical Research Consortium for Spinocerebellar Ataxias (CRC-SCA) to Study Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias (SCA)

Details

Keywords

Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia Type 6, Spinocerebellar Ataxia, Natural History, Genetic Modifiers, DNA testing, Ataxia, Cerebellar Ataxia, Spinocerebellar Ataxias, Spinocerebellar Degenerations, Machado-Joseph Disease, All Participants, Spinocerebellar Ataxia 1, Spinocerebellar Ataxia 2, Spinocerebellar Ataxia 3, Spinocerebellar Ataxia 6

Eligibility

Locations

  • UCSF accepting new patients
    San Francisco California 94115 United States
  • University of California Los Angeles accepting new patients
    Los Angeles California 90095 United States

Lead Scientist at UCSF

  • Michael Geschwind, MD
    Dr. Geschwind received his M.D.and Ph.D. in neuroscience through the National Institutes of Health (NIH)-sponsored Medical Scientist Training Program (MSTP) at the Albert Einstein College of Medicine in New York.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of Florida
Links
National Ataxia Foundation
ID
NCT01060371
Study Type
Observational
Participants
Expecting 800 study participants
Last Updated